FMT to Convert Response to Immunotherapy

Clinical trial NCT05251389 · RECRUITING

Trial details

NCT number: NCT05251389
Sponsor: The Netherlands Cancer Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Stage III Melanoma Stage IV

Start date: 2022-08-31
Primary completion: 2026-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.